0.50Open0.50Pre Close0 Volume21 Open Interest1.00Strike Price0.00Turnover182.94%IV36.99%PremiumJan 17, 2025Expiry Date0.10Intrinsic Value100Multiplier25DDays to Expiry0.41Extrinsic Value100Contract SizeAmericanOptions Type0.6682Delta0.6944Gamma4.38Leverage Ratio-0.0039Theta0.0003Rho2.93Eff Leverage0.0010Vega
TherapeuticsMD Stock Discussion
The company also released its Q3 financial report, posting a net loss from continuing operations of $0.13 per share...
• $AmerisourceBergen (ABC.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $178 (from $167)
• $Arch Resources (ARCH.US)$ : Jefferies Upgrades to Buy From Hold - PT $225 (from $160)
• $BHP Group Ltd (BHP.US)$ : Jefferies Upgrades to Buy From Hold - PT $82 (from $72)
• $Peabody Energy (BTU.US)$ : Jefferies Upgrades to Buy From Hold - PT $36 (from $25)
• $Warrior Met Coal (HCC.US)$ : Jefferies Upgrades to Buy From Hold - PT $50 (from $36)
• $Liberty Global-A (LBTYA.US)$ : Berenbe...
• $Boot Barn Holdings (BOOT.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $121 (from $109)
• $EPAM Systems (EPAM.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $400 (from $312)
• $Hersha Hospitality Trust (HT.US)$ : Stifel Upgrades to Buy from Hold - PT $14.50 (from $11)
• $Jounce Therapeutics (JNCE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $20 (from $15)
• $Pactiv Evergreen (PTVE.US)$ : RBC Capital Upgra...
No comment yet